Skip to main content

Author: Customer Service

SONORO ANNOUNCES UPDATED MINERAL RESOURCE ESTIMATE AND ROBUST UPDATED PEA FOR CERRO CALICHE GOLD PROJECT: AFTER-TAX NPV OF USD $224 MILLION AND AFTER-TAX IRR OF 50%

VANCOUVER, Canada, Feb. 28, 2026 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce the results of an independent updated Mineral Resource Estimate (“MRE”) and updated Preliminary Economic Assessment (“PEA”) on the Company’s Cerro Caliche gold project located in Sonora State, Mexico. The PEA demonstrates the potential viability for a ten-year life of mine (“LOM”), open pit, heap leach mining operation with an initial one-year ramp up production rate of 12,000 tonnes per day (“tpd”) and an increase to 16,000 tpd for the remaining LOM. All currency is stated as USD. The updated MRE and PEA have been prepared in accordance with the requirements of National Instrument 43-101 (“NI 43-101”) by P&E Mining Consultants Inc., of Brampton, Ontario (“P&E”). Updated...

Continue reading

Micron Celebrates Opening of India’s First Semiconductor Assembly and Test Facility

State-of-the-art site in Sanand, Gujarat, expands Micron’s global footprint and advances India’s semiconductor ecosystem SANAND, India, Feb. 28, 2026 (GLOBE NEWSWIRE) — Micron Technology, Inc. (NASDAQ: MU) today celebrated the grand opening of its semiconductor assembly and test facility in Sanand, Gujarat, India. The state-of-the-art facility converts advanced DRAM and NAND wafers from Micron’s global manufacturing network into finished memory and storage products. Once fully ramped, the first phase of Micron’s Sanand operation will feature more than 500,000 square feet of cleanroom space, making it one of the world’s largest single-floor assembly and test cleanrooms. The site serves customers worldwide to meet the growing global demand for memory and storage fueled by AI. The facility represents a combined investment...

Continue reading

Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance to Advance AI-Driven Chronic Care Services

BEIJING, Feb. 28, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has signed a strategic collaboration agreement with Youcare Pharmaceutical Group (悦康药业集团 or “Youcare”) (SH: 688658), a leading integrated pharmaceutical enterprise in China. The partnership aims to accelerate the digital transformation and enhancement of chronic disease services through the application of artificial intelligence (“AI”).Fangzhou and Youcare Pharmaceutical Group Form Strategic Alliance The agreement outlines a joint commitment to applying AI across various chronic care scenarios and upgrading full-lifecycle health management solutions. The two companies plan to build a more accessible, efficient, and precision-oriented healthcare service ecosystem, supporting...

Continue reading

SQM Reports Earnings for the Twelve Months Ended December 31, 2025

HighlightsSQM reported total revenues for the twelve months ended December 31, 2025 of US$4,576.2 million compared to total revenues of US$4,528.8 million for the same period last year.Net income for the twelve months ended December 31, 2025 of US$588.1 million or US$2.06 per share, compared to net loss of US$(404.4) million or US$(1.42) per share for the same period last year.In lithium: Record quarterly sales volumes amidst strong market demandStrong price environment in iodine SQM will hold a conference call to discuss these results on Monday, March 2, 2026 at 10:00am EST (12:00pm Chile time).Participant Call link:https://register-conf.media-server.com/register/BI256bddfcaae643f591a9cfc6b2a449d6Webcast:https://edge.media-server.com/mmc/p/f6nxktxeSANTIAGO, Chile, Feb. 27, 2026 (GLOBE NEWSWIRE)...

Continue reading

EQV Ventures Acquisition Corp. Shareholders Approve Business Combination with Presidio

Transaction expected to close on or about March 4, 2026 Fort Worth, TX, Feb. 27, 2026 (GLOBE NEWSWIRE) — EQV Ventures Acquisition Corp. (NYSE: FTW) (“EQV”), a special purpose acquisition company sponsored by EQV Group, is pleased to announce that in an extraordinary general meeting held today, EQV shareholders voted to approve the previously announced business combination with Presidio Investment Holdings LLC (“Presidio” or the “Company”), a differentiated oil and gas operator focused on the acquisition and optimization of mature, producing oil and natural gas assets in the United States. A Form 8-K disclosing the full voting results will be filed with the Securities and Exchange Commission. The closing of the business combination is expected to occur on or about March 4, 2026, subject to the satisfaction or waiver of all closing...

Continue reading

Mission Success: Rocket Lab Launches 2nd Hypersonic Test Mission in Three Months for Defense Innovation Unit

LONG BEACH, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its latest hypersonic test mission on its HASTE rocket for the Department of War’s Defense Innovation Unit (DIU) – supporting a critical national priority to advance hypersonic technology for the United States and its allies. “That’s Not A Knife” lifted off on February 27 at 7:00 p.m. Eastern (February 28, 00:00 UTC) from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority’s Mid-Atlantic Regional Spaceport on Wallops Island, Virginia – the second successful launch of a hypersonic test mission for the DIU in three months and 7th HASTE launch overall. The mission deployed DART AE, a scramjet-powered aircraft developed...

Continue reading

YY Group Announces US$20 Million At-The-Market Offering Facility

SINGAPORE, Feb. 27, 2026 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that it has entered into an At The Market Sales Agreement (the “ATM Agreement”) with Spartan Capital Securities, LLC (“Spartan”) and Wilson-Davis & Co., Inc. (“WDCO,” and together with Spartan, the “Sales Agents”), pursuant to which the Company may offer and sell, from time to time, up to US$20,000,000 of its Class A Ordinary Shares through the Sales Agents, acting as sales agents. Sales of the shares, if any, will be made at market prices by methods deemed to be an “at the market offering” as defined in Rule 415 under the Securities Act, including without limitation sales made directly...

Continue reading

Brookfield Property Partners Completes 2025 Annual Filings

BROOKFIELD NEWS, Feb. 27, 2026 (GLOBE NEWSWIRE) — Brookfield Property Partners announced today that it has filed its 2025 annual report on Form 20-F, including its audited financial statements for the year ended December 31, 2025, with the SEC on EDGAR as well as with the Canadian securities authorities on SEDAR+. These documents are also available at bpy.brookfield.com. Brookfield Property Partners Brookfield Property Partners is one of the world’s premier real estate companies. We own and operate iconic properties in the world’s major markets, and our global portfolio includes office, retail, multifamily, logistics, hospitality, single-family rentals, manufactured housing, student housing and self-storage. Brookfield Property Partners is a subsidiary of Brookfield Corporation (NYSE: BN, TSX: BN). More information is available...

Continue reading

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing interval Commercial availability expected during early part of Q2 2026 Rare Pediatric Disease Priority Review Voucher granted in connection with approval Ascendis to host investor conference call Monday, March 2, at 8:00 am ETCOPENHAGEN, Denmark, Feb. 27, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has granted approval under the FDA’s Accelerated Approval Program for YUVIWEL® (navepegritide; developed as TransCon® CNP), the first and only once-weekly treatment indicated to increase linear growth in children 2 years of age and older with achondroplasia with open epiphyses and the only one to provide continuous systemic exposure...

Continue reading

OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.

CLARKSBURG, Md., Feb. 27, 2026 (GLOBE NEWSWIRE) — OpGen, Inc. (OTC: OPGN) today announced that it is changing its name to CapForce Inc., effective today. OpGen changed its name to CapForce Inc. in order to reflect the repositioning of the Company’s business to the digital investment banking and financial technology sectors. The name “CapForce” represents the “Force of Capital,” symbolizing the Company’s conviction as a next-generation category-defining fintech-powered investment bank that harnesses the intrinsic force of capital, through capital markets as the empowerment medium, to empower global mid-sized high growth companies to grow beyond the small-cap universe and punch above their weight to enter the mid-cap or even large-cap universe. In connection with the name change, the Company expects to change its ticker symbol to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.